Centre Hospitalier de L'Universite de Montreal — Montreal, Quebec

Public research footprint of Centre Hospitalier de L'Universite de Montreal, compiled from the ClinicalTrials.gov public registry.

375

Registered studies

138

Active

Recruiting now

191

Completed

Stopped or withdrawn

Most-studied conditions

Breast Cancer · Recurrent Endometrial Clear Cell Adenocarcinoma · Recurrent Endometrial Dedifferentiated Carcinoma · Relapsed/Refractory Follicular Lymphoma

Recently updated registry entries

NCT06790693 — A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and… (Recruiting)
NCT06065748 — A Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a… (Recruiting)
NCT07287150 — A Study to Test Inavolisib Treatment in Participants With Metastatic Castration-Resistant… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Centre Hospitalier de L'Universite de Montreal?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 05, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.